Cormorant Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-893,500
| Closed | -$5.89M | – | 111 |
|
|
2021
Q2 | $5.89M | Sell |
893,500
-606,500
| -40% | -$4M | 0.2% | 75 |
|
|
2021
Q1 | $11M | Buy |
+1,500,000
| New | +$11M | 0.24% | 65 |
|
|
2020
Q4 | – | Sell |
-1,000,000
| Closed | -$5.94M | – | 114 |
|
|
2020
Q3 | $5.94M | Sell |
1,000,000
-350,000
| -26% | -$2.08M | 0.23% | 66 |
|
|
2020
Q2 | $6.95M | Buy |
+1,350,000
| New | +$6.95M | 0.27% | 59 |
|
|
2017
Q2 | – | Sell |
-70,000
| Closed | -$413K | – | 81 |
|
|
2017
Q1 | $413K | Sell |
70,000
-38,772
| -36% | -$229K | 0.06% | 70 |
|
|
2016
Q4 | $587K | Hold |
108,772
| – | – | 0.08% | 69 |
|
|
2016
Q3 | $968K | Hold |
108,772
| – | – | 0.11% | 71 |
|
|
2016
Q2 | $1.05M | Hold |
108,772
| – | – | 0.15% | 66 |
|
|
2016
Q1 | $1M | Hold |
108,772
| – | – | 0.15% | 70 |
|
|
2015
Q4 | $1.37M | Sell |
108,772
-50,000
| -31% | -$630K | 0.16% | 66 |
|
|
2015
Q3 | $1.92M | Hold |
158,772
| – | – | 0.31% | 64 |
|
|
2015
Q2 | $2.76M | Buy |
+158,772
| New | +$2.76M | 0.37% | 54 |
|